Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting Induced by Radiochemotherapy in Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC) Interventions: Drug: Netopitam Palonosetron capsules and dexamethasone Sponsors: Sichuan Cancer Hospital and Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV
Condition: Nausea and Vomiting Intervention: Drug: Palonosetron hydrochloride capsules Sponsor: Xijing Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2023 Category: Research Source Type: clinical trials
Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors
Condition: Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy Interventions: Drug: HR20013 for injection；dexamethasone; Drug: fosaprepitant dimeglumine for injection；palonosetron hydrochloride injection；dexamethasone Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2022 Category: Research Source Type: clinical trials
